Therapeutic drug monitoring of antithyroid drugs in pregnancy: The knowledge gaps

Gideon Koren, Offie Soldin

Research output: Contribution to journalShort surveypeer-review

9 Scopus citations

Abstract

Despite being a common condition in pregnancy, and despite propylthiouracil (PTU) being perceived as safer than methimazole, there are virtually no epidemiological controlled studies on malformation rate an neurobehavioral outcomes with the former. This knowledge gap must be filled to ensure fetal safety.

Original languageEnglish
Pages (from-to)12-13
Number of pages2
JournalTherapeutic Drug Monitoring
Volume28
Issue number1
DOIs
StatePublished - Feb 2006
Externally publishedYes

Keywords

  • Antithyroid
  • Malformations
  • Pregnancy
  • Therapeutic drug monitoring
  • Thyrotoxicosis

Fingerprint

Dive into the research topics of 'Therapeutic drug monitoring of antithyroid drugs in pregnancy: The knowledge gaps'. Together they form a unique fingerprint.

Cite this